01.8.2020 – AC Immune is one of three winners sharing USD 10 million through The Michael J. Fox Foundation Ken Griffin Alpha-synuclein Imaging Competition.
The award follows compelling preclinical results presented at AAIC on the Company’s alpha-synuclein positron emission tomography -(PET) tracer program. Further validates the ability of AC Immune’s proprietary platforms to accelerate delivery of a new class of promising diagnostics in neurodegenerative diseases.
Read more on AC Immune’s website